A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research

por Laccetti, Andrew L, Morris, Michael J, Kantoff, Philip W
Publicado 2020

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer

por Gui, Bin, Hsieh, Chen-Lin, Kantoff, Philip W., Kibel, Adam S., Jia, Li
Publicado 2017

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

por Braunstein, Lior Z., Chen, Ming-Hui, Loffredo, Marian, Kantoff, Philip W., D'Amico, Anthony V.
Publicado 2014

Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer

por Mazzu, Ying Z., Yoshikawa, Yuki, Nandakumar, Subhiksha, Chakraborty, Goutam, Armenia, Joshua, Jehane, Lina E., Lee, Gwo‐Shu Mary, Kantoff, Philip W.
Publicado 2019

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators

por Martin, Neil E., Chen, Ming-Hui, Beard, Clair J., Nguyen, Paul L., Loffredo, Marian J., Renshaw, Andrew A., Kantoff, Philip W., D'Amico, Anthony V.
Publicado 2014

Androgen Deprivation Therapy Reversibly Increases Endothelium‐Dependent Vasodilation in Men With Prostate Cancer

por Nguyen, Paul L., Jarolim, Petr, Basaria, Shehzad, Zuflacht, Jonah P., Milian, Jessica, Kadivar, Samoneh, Graham, Powell L., Hyatt, Andrew, Kantoff, Philip W., Beckman, Joshua A.
Publicado 2015

Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer

por Du, Zhou, Sun, Tong, Hacisuleyman, Ezgi, Fei, Teng, Wang, Xiaodong, Brown, Myles, Rinn, John L., Lee, Mary Gwo-Shu, Chen, Yiwen, Kantoff, Philip W., Liu, X. Shirley
Publicado 2016

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer

por Sun, Tong, Du, Shin-Yi, Armenia, Joshua, Qu, Fangfang, Fan, Jingyu, Wang, Xiaodong, Fei, Teng, Komura, Kazumasa, Liu, Shirley X., Lee, Gwo-Shu Mary, Kantoff, Philip W
Publicado 2018

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

por Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, Gwo‐Shu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.
Publicado 2020

Evaluation of an RNAseq-Based Immunogenomic Liquid Biopsy Approach in Early-Stage Prostate Cancer

por Van Neste, Leander, Wojno, Kirk J., Henao, Ricardo, Mane, Shrikant, Korman, Howard, Hafron, Jason, Kernen, Kenneth, Tinawi-Aljundi, Rima, Putzi, Mathew, Kassis, Amin I., Kantoff, Philip W.
Publicado 2021

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

por Sheikh, Nadeem A., Petrylak, Daniel, Kantoff, Philip W., dela Rosa, Corazon, Stewart, Frances P., Kuan, Ling-Yu, Whitmore, James B., Trager, James B., Poehlein, Christian H., Frohlich, Mark W., Urdal, David L.
Publicado 2012

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer

por Gagliano-Jucá, Thiago, Travison, Thomas G, Kantoff, Philip W, Nguyen, Paul L, Taplin, Mary-Ellen, Kibel, Adam S, Huang, Grace, Bearup, Richelle, Schram, Haley, Manley, Robert, Beleva, Yusnie M, Edwards, Robert R, Basaria, Shehzad
Publicado 2018

Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays

por Stopsack, Konrad H, Tyekucheva, Svitlana, Wang, Molin, Gerke, Travis A, Vaselkiv, J Bailey, Penney, Kathryn L, Kantoff, Philip W, Finn, Stephen P, Fiorentino, Michelangelo, Loda, Massimo, Lotan, Tamara L, Parmigiani, Giovanni, Mucci, Lorelei A
Publicado 2021

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

por Bambury, Richard M, Bhatt, Ami S, Riester, Markus, Pedamallu, Chandra Sekhar, Duke, Fujiko, Bellmunt, Joaquim, Stack, Edward C, Werner, Lillian, Park, Rachel, Iyer, Gopa, Loda, Massimo, Kantoff, Philip W, Michor, Franziska, Meyerson, Matthew, Rosenberg, Jonathan E
Publicado 2015

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

por Xu, Kexin, Wu, Zhenhua Jeremy, Groner, Anna C, He, Housheng Hansen, Cai, Changmeng, Stack, Edward C, Loda, Massimo, Liu, Tao, Morrissey, Colm, Vessella, Robert L, Kantoff, Philip W, Balk, Steven P, Liu, X Shirley, Brown, Myles
Publicado 2013

Germline Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes after Radiation Therapy for Prostate Cancer: Results from a Test and Validation Set Analysis

por Margalit, Danielle N., Jordahl, Kristina M., Werner, Lillian, Wang, Xiaodong, Lee, Mary Gwo-Shu, Penney, Kathryn L., Batista, Julie L., Martin, Neil E., Chan, June M., Kantoff, Philip W., Stampfer, Meir J., Nguyen, Paul L., Mucci, Lorelei A.
Publicado 2015

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study

por Kelly, Rachel S., Sinnott, Jennifer A., Rider, Jennifer R., Ebot, Ericka M., Gerke, Travis, Bowden, Michaela, Pettersson, Andreas, Loda, Massimo, Sesso, Howard D., Kantoff, Philip W., Martin, Neil E., Giovannucci, Edward L., Tyekucheva, Svitlana, Heiden, Matthew Vander, Mucci, Lorelei A.
Publicado 2016

Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity

por Mazzu, Ying Z., Liao, YuRou, Nandakumar, Subhiksha, Sjöström, Martin, Jehane, Lina E., Ghale, Romina, Govindarajan, Barani, Gerke, Travis A., Lee, Gwo‐Shu Mary, Luo, Jian‐Hua, Chinni, Sreenivasa R., Mucci, Lorelei A., Feng, Felix Y., Kantoff, Philip W.
Publicado 2022

Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer

por Mazzu, Ying Z., Liao, Yu-Rou, Nandakumar, Subhiksha, Jehane, Lina E., Koche, Richard P., Rajanala, Sai Harisha, Li, Ruifang, Zhao, HuiYong, Gerke, Travis A., Chakraborty, Goutam, Lee, Gwo-Shu Mary, Nanjangud, Gouri J., Gopalan, Anuradha, Chen, Yu, Kantoff, Philip W.
Publicado 2022

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

por Pomerantz, Mark M., Li, Fugen, Takeda, David, Lenci, Romina, Chonkar, Apurva, Chabot, Matthew, Cejas, Paloma, Vazquez, Francisca, Cook, Jennifer, Shivdasani, Ramesh A., Bowden, Michaela, Lis, Rosina, Hahn, William C., Kantoff, Philip W., Brown, Myles, Loda, Massimo, Long, Henry W., Freedman, Matthew L.
Publicado 2015